{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T13:51:20Z","timestamp":1787579480616,"version":"build-2736575974"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T00:00:00Z","timestamp":1606176000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T00:00:00Z","timestamp":1606176000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Metabolic healthy obesity (MHO), a phenotype of obesity, seems to be associated with a lower risk of cardiovascular disease. However, MHO has a close relationship with a higher incidence of metabolic syndrome and diabetes. This study aimed to investigate the prevalence of MHO at baseline, the changes in the obese metabolic phenotype at follow-up and the relationship of this phenotype with the incidence of mildly reduced estimated glomerular filtration rate (eGFR) in rural Northeast Chinese.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      The Chronic Kidney Disease Epidemiology (CKD-EPI) equation was used to calculate eGFR. A total of 4903 participants aged \u226535\u2009years with eGFR &gt;\u200990\u2009ml\/min\/1.73\u2009m\n                      <jats:sup>2<\/jats:sup>\n                      at baseline were enrolled and successfully followed. All participants completed the questionnaires, anthropometric measurements, and blood tests during baseline and follow-up. Mild renal dysfunction was defined as mildly reduced eGFR between 60 and 90\u2009ml\/min\/1.73\u2009m\n                      <jats:sup>2<\/jats:sup>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The prevalence of MHO was 20.0% at baseline (19.0% for women and 21.1% for men), which was secondary to metabolic abnormal obesity (MAO) (24.4, 27.2% for women and 21.5% for men). A total of 38.4% of women and 38.9% of men experienced phenotypic changes during follow-up. The cumulative incidence of mildly reduced eGFR in the MHO group was 20.1% (17.7% for women and 22.3% for men), which was also secondary to the incidence in the MAO group (20.8, 18.6% for women and 23.5% for men). After adjusting for age, current smoking, current drinking, chronic diseases, LDL-C, ALT, and AST, MHO was associated with a higher incidence of mildly reduced eGFR among women [OR (95% CI) =1.6 (1.2, 2.3)] and men [OR (95% CI) =1.6(1.2, 2.1)], whereas MAO was related to a higher incidence of mildly reduced eGFR among men only [OR (95% CI) =1.7 (1.3, 2.3)].<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>MHO was associated with a higher incidence of mildly reduced eGFR in both sexes; however, there was a specific relationship between MAO and mildly reduced eGFR in men only. Therefore, it is necessary to monitor kidney function among participants with both MHO and MAO.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12882-020-02164-2","type":"journal-article","created":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T14:04:39Z","timestamp":1606226679000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Metabolic healthy obesity is associated with higher incidence of mild decrease estimate glomerular rate in rural northeast Chinese"],"prefix":"10.1186","volume":"21","author":[{"given":"Shasha","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang Xiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqiang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingxian","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,24]]},"reference":[{"issue":"10","key":"2164_CR1","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1093\/aje\/kwn033","volume":"167","author":"BC Astor","year":"2008","unstructured":"Astor BC, Hallan SI, Miller ER 3rd, Yeung E, Coresh J. Glomerular filtration rate, albuminuria, and risk of cardiovascular and all-cause mortality in the US population. Am J Epidemiol. 2008;167(10):1226\u201334.","journal-title":"Am J Epidemiol"},{"issue":"1","key":"2164_CR2","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/S0735-1097(02)02663-3","volume":"41","author":"G Manjunath","year":"2003","unstructured":"Manjunath G, Tighiouart H, Ibrahim H, MacLeod B, Salem DN, Griffith JL, Coresh J, Levey AS, Sarnak MJ. Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community. J Am Coll Cardiol. 2003;41(1):47\u201355.","journal-title":"J Am Coll Cardiol"},{"issue":"22","key":"2164_CR3","doi-asserted-by":"publisher","first-page":"2659","DOI":"10.1001\/archinte.165.22.2659","volume":"165","author":"JJ Brugts","year":"2005","unstructured":"Brugts JJ, Knetsch AM, Mattace-Raso FU, Hofman A, Witteman JC. Renal function and risk of myocardial infarction in an elderly population: the Rotterdam study. Arch Intern Med. 2005;165(22):2659\u201365.","journal-title":"Arch Intern Med"},{"key":"2164_CR4","doi-asserted-by":"publisher","first-page":"b2392","DOI":"10.1136\/bmj.b2392","volume":"338","author":"T Kurth","year":"2009","unstructured":"Kurth T, de Jong PE, Cook NR, Buring JE, Ridker PM. Kidney function and risk of cardiovascular disease and mortality in women: a prospective cohort study. BMJ (Clin Res ed). 2009;338:b2392.","journal-title":"BMJ (Clin Res ed)"},{"issue":"3","key":"2164_CR5","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.ccl.2010.04.007","volume":"28","author":"TS Polonsky","year":"2010","unstructured":"Polonsky TS, Locatelli F. The contribution of early nephropathy to cardiovascular risk. Cardiol Clin. 2010;28(3):427\u201336.","journal-title":"Cardiol Clin"},{"key":"2164_CR6","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1146\/annurev-publhealth-031816-044604","volume":"38","author":"ND Ford","year":"2017","unstructured":"Ford ND, Patel SA, Narayan KM. Obesity in low- and middle-income countries: burden, drivers, and emerging challenges. Annu Rev Public Health. 2017;38:145\u201364.","journal-title":"Annu Rev Public Health"},{"issue":"1","key":"2164_CR7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1753-4887.2011.00456.x","volume":"70","author":"BM Popkin","year":"2012","unstructured":"Popkin BM, Adair LS, Ng SW. Global nutrition transition and the pandemic of obesity in developing countries. Nutr Rev. 2012;70(1):3\u201321.","journal-title":"Nutr Rev"},{"issue":"61","key":"2164_CR8","first-page":"4","volume":"16","author":"NK Sainju","year":"2018","unstructured":"Sainju NK, Shah RK, Joshi SK. Screening for hypertension and obesity in rural population of Nepal. Kathmandu Univ Med J (KUMJ). 2018;16(61):4\u20137.","journal-title":"Kathmandu Univ Med J (KUMJ)"},{"issue":"8","key":"2164_CR9","doi-asserted-by":"publisher","first-page":"e021363","DOI":"10.1136\/bmjopen-2017-021363","volume":"8","author":"RK Rai","year":"2018","unstructured":"Rai RK, Jaacks LM, Bromage S, Barik A, Fawzi WW, Chowdhury A. Prospective cohort study of overweight and obesity among rural Indian adults: sociodemographic predictors of prevalence, incidence and remission. BMJ Open. 2018;8(8):e021363.","journal-title":"BMJ Open"},{"issue":"4","key":"2164_CR10","first-page":"3267","volume":"15","author":"T Trivedi","year":"2015","unstructured":"Trivedi T, Liu J, Probst J, Merchant A, Jhones S, Martin AB. Obesity and obesity-related behaviors among rural and urban adults in the USA. Rural Remote Health. 2015;15(4):3267.","journal-title":"Rural Remote Health"},{"issue":"1","key":"2164_CR11","doi-asserted-by":"publisher","first-page":"5012","DOI":"10.1038\/s41598-017-04135-4","volume":"7","author":"Y He","year":"2017","unstructured":"He Y, Pan A, Wang Y, Yang Y, Xu J, Zhang Y, Liu D, Wang Q, Shen H, Zhang Y, et al. Prevalence of overweight and obesity in 15.8 million men aged 15\u201349 years in rural China from 2010 to 2014. Sci Rep. 2017;7(1):5012.","journal-title":"Sci Rep"},{"issue":"1","key":"2164_CR12","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.ypmed.2008.10.020","volume":"48","author":"H Tian","year":"2009","unstructured":"Tian H, Xie H, Song G, Zhang H, Hu G. Prevalence of overweight and obesity among 2.6 million rural Chinese adults. Prev Med. 2009;48(1):59\u201363.","journal-title":"Prev Med"},{"issue":"1","key":"2164_CR13","doi-asserted-by":"publisher","first-page":"65","DOI":"10.5935\/0101-2800.20170011","volume":"39","author":"GB Silva Junior","year":"2017","unstructured":"Silva Junior GB, Bentes AC, Daher EF, Matos SM. Obesity and kidney disease. J Bras Nefrol. 2017;39(1):65\u20139.","journal-title":"J Bras Nefrol"},{"issue":"10","key":"2164_CR14","doi-asserted-by":"publisher","first-page":"4075","DOI":"10.1210\/jc.2007-2724","volume":"93","author":"CA Aguilar-Salinas","year":"2008","unstructured":"Aguilar-Salinas CA, Garc\u00eda EG, Robles L, Ria\u00f1o D, Ruiz-Gomez DG, Garc\u00eda-Ulloa AC, Melgarejo MA, Zamora M, Guillen-Pineda LE, Mehta R, et al. High adiponectin concentrations are associated with the metabolically healthy obese phenotype. J Clin Endocrinol Metab. 2008;93(10):4075\u20139.","journal-title":"J Clin Endocrinol Metab"},{"issue":"15","key":"2164_CR15","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1001\/archinte.168.15.1617","volume":"168","author":"RP Wildman","year":"2008","unstructured":"Wildman RP, Muntner P, Reynolds K, McGinn AP, Rajpathak S, Wylie-Rosett J, Sowers MR. The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). Arch Intern Med. 2008;168(15):1617\u201324.","journal-title":"Arch Intern Med"},{"issue":"7","key":"2164_CR16","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.1210\/jc.2011-3475","volume":"97","author":"M Hamer","year":"2012","unstructured":"Hamer M, Stamatakis E. Metabolically healthy obesity and risk of all-cause and cardiovascular disease mortality. J Clin Endocrinol Metab. 2012;97(7):2482\u20138.","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2164_CR17","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.2337\/dc12-1971","volume":"36","author":"SL Appleton","year":"2013","unstructured":"Appleton SL, Seaborn CJ, Visvanathan R, Hill CL, Gill TK, Taylor AW, Adams RJ. Diabetes and cardiovascular disease outcomes in the metabolically healthy obese phenotype: a cohort study. Diabetes Care. 2013;36(8):2388\u201394.","journal-title":"Diabetes Care"},{"key":"2164_CR18","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1186\/1471-2458-14-877","volume":"14","author":"S Yu","year":"2014","unstructured":"Yu S, Guo X, Yang H, Zheng L, Sun Y. An update on the prevalence of metabolic syndrome and its associated factors in rural Northeast China. BMC Public Health. 2014;14:877.","journal-title":"BMC Public Health"},{"issue":"5","key":"2164_CR19","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.jash.2015.02.014","volume":"9","author":"Z Li","year":"2015","unstructured":"Li Z, Guo X, Zheng L, Yang H, Sun Y. Grim status of hypertension in rural China: results from Northeast China rural cardiovascular health study 2013. J Am Soc Hypertension. 2015;9(5):358\u201364.","journal-title":"J Am Soc Hypertension"},{"issue":"12","key":"2164_CR20","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1038\/oby.2004.239","volume":"12","author":"DB Panagiotakos","year":"2004","unstructured":"Panagiotakos DB, Pitsavos C, Chrysohoou C, Risvas G, Kontogianni MD, Zampelas A, Stefanadis C. Epidemiology of overweight and obesity in a Greek adult population: the ATTICA study. Obes Res. 2004;12(12):1914\u201320.","journal-title":"Obes Res"},{"issue":"19","key":"2164_CR21","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","volume":"289","author":"AV Chobanian","year":"2003","unstructured":"Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, et al. The seventh report of the joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA. 2003;289(19):2560\u201372.","journal-title":"JAMA"},{"issue":"9","key":"2164_CR22","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604\u201312.","journal-title":"Ann Intern Med"},{"issue":"3","key":"2164_CR23","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.numecd.2013.07.005","volume":"24","author":"KC Sung","year":"2014","unstructured":"Sung KC, Cha SC, Sung JW, So MS, Byrne CD. Metabolically healthy obese subjects are at risk of fatty liver but not of pre-clinical atherosclerosis. Nutr Metab Cardiovasc Dis. 2014;24(3):256\u201362.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"16","key":"2164_CR24","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","volume":"120","author":"KG Alberti","year":"2009","unstructured":"Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC Jr. Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; National Heart, Lung, and Blood Institute; American Heart Association; world heart federation; international atherosclerosis society; and International Association for the Study of obesity. Circulation. 2009;120(16):1640\u20135.","journal-title":"Circulation"},{"issue":"Suppl 2","key":"2164_CR25","doi-asserted-by":"publisher","first-page":"S1037","DOI":"10.1016\/j.dsx.2017.07.036","volume":"11","author":"SM Latifi","year":"2017","unstructured":"Latifi SM, Karandish M, Shahbazian H, Taha JM, Cheraghian B, Moradi M. Prevalence of metabolically healthy obesity (MHO) and its relation with incidence of metabolic syndrome, hypertension and type 2 diabetes amongst individuals aged over 20 years in Ahvaz: a 5 year cohort study (2009-2014). Diab Metab Syndrome. 2017;11(Suppl 2):S1037\u2013s1040.","journal-title":"Diab Metab Syndrome"},{"issue":"9","key":"2164_CR26","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1177\/0003319714542461","volume":"65","author":"F Akin","year":"2014","unstructured":"Akin F, Celik O, Altun I, Ay\u00e7a B. Association of glomerular filtration rate with slow coronary flow in patients with normal to mildly impaired renal function. Angiology. 2014;65(9):850.","journal-title":"Angiology"},{"issue":"4","key":"2164_CR27","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.ahj.2006.12.025","volume":"153","author":"K Nasir","year":"2007","unstructured":"Nasir K, Rosen BD, Kramer HJ, Edvardsen T, Bluemke DA, Liu K, Lima JA. Regional left ventricular function in individuals with mild to moderate renal insufficiency: the multi-ethnic study of atherosclerosis. Am Heart J. 2007;153(4):545\u201351.","journal-title":"Am Heart J"},{"issue":"6","key":"2164_CR28","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.2215\/CJN.01880507","volume":"2","author":"M Yoshida","year":"2007","unstructured":"Yoshida M, Tomiyama H, Yamada J, Koji Y, Shiina K, Nagata M, Yamashina A. Relationships among renal function loss within the normal to mildly impaired range, arterial stiffness, inflammation, and oxidative stress. Clin J Am Soc Nephrol. 2007;2(6):1118\u201324.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"2164_CR29","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1681\/ASN.2005080834","volume":"17","author":"F Stam","year":"2006","unstructured":"Stam F, van Guldener C, Becker A, Dekker JM, Heine RJ, Bouter LM, Stehouwer CD. Endothelial dysfunction contributes to renal function-associated cardiovascular mortality in a population with mild renal insufficiency: the Hoorn study. J Am Soc Nephrol. 2006;17(2):537\u201345.","journal-title":"J Am Soc Nephrol"},{"key":"2164_CR30","doi-asserted-by":"crossref","unstructured":"Miranda-D\u00edaz AG, Pazar\u00edn-Villase\u00f1or L, Yanowsky-Escatell FG, Andrade-Sierra J: Oxidative stress in diabetic nephropathy with early chronic kidney disease. J Diab Res 2016, 2016:7047238.","DOI":"10.1155\/2016\/7047238"},{"issue":"9","key":"2164_CR31","doi-asserted-by":"publisher","first-page":"e0137449","DOI":"10.1371\/journal.pone.0137449","volume":"10","author":"T Toyama","year":"2015","unstructured":"Toyama T, Furuichi K, Shimizu M, Hara A, Iwata Y, Sakai N, Perkovic V, Kobayashi M, Mano T, Kaneko S, et al. Relationship between serum uric acid levels and chronic kidney disease in a Japanese cohort with Normal or mildly reduced kidney function. PLoS One. 2015;10(9):e0137449.","journal-title":"PLoS One"},{"key":"2164_CR32","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1472-6823-14-9","volume":"14","author":"JV van Vliet-Ostaptchouk","year":"2014","unstructured":"van Vliet-Ostaptchouk JV, Nuotio ML, Slagter SN, Doiron D, Fischer K, Foco L, Gaye A, G\u00f6gele M, Heier M, Hiekkalinna T, et al. The prevalence of metabolic syndrome and metabolically healthy obesity in Europe: a collaborative analysis of ten large cohort studies. BMC Endocr Disord. 2014;14:9.","journal-title":"BMC Endocr Disord"},{"issue":"5","key":"2164_CR33","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1097\/MED.0b013e328357f0a3","volume":"19","author":"M Bl\u00fcher","year":"2012","unstructured":"Bl\u00fcher M. Are there still healthy obese patients? Curr Opinion Endocrinol Diab Obes. 2012;19(5):341\u20136.","journal-title":"Curr Opinion Endocrinol Diab Obes"},{"key":"2164_CR34","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1186\/1471-2458-11-754","volume":"11","author":"P Pajunen","year":"2011","unstructured":"Pajunen P, Kotronen A, Korpi-Hy\u00f6v\u00e4lti E, Kein\u00e4nen-Kiukaanniemi S, Oksa H, Niskanen L, Saaristo T, Saltevo JT, Sundvall J, Vanhala M, et al. Metabolically healthy and unhealthy obesity phenotypes in the general population: the FIN-D2D survey. BMC Public Health. 2011;11:754.","journal-title":"BMC Public Health"},{"issue":"2","key":"2164_CR35","first-page":"227","volume":"21","author":"LC Hwang","year":"2012","unstructured":"Hwang LC, Bai CH, Sun CA, Chen CJ. Prevalence of metabolically healthy obesity and its impacts on incidences of hypertension, diabetes and the metabolic syndrome in Taiwan. Asia Pac J Clin Nutr. 2012;21(2):227\u201333.","journal-title":"Asia Pac J Clin Nutr"},{"issue":"2","key":"2164_CR36","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/j.1751-7176.2011.00565.x","volume":"14","author":"R Cherqaoui","year":"2012","unstructured":"Cherqaoui R, Kassim TA, Kwagyan J, Freeman C, Nunlee-Bland G, Ketete M, Xu S, Randall OS. The metabolically healthy but obese phenotype in African Americans. J Clin Hypertension (Greenwich, Conn). 2012;14(2):92\u20136.","journal-title":"J Clin Hypertension (Greenwich, Conn)"},{"issue":"2","key":"2164_CR37","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/S2213-8587(13)70062-7","volume":"1","author":"N Stefan","year":"2013","unstructured":"Stefan N, H\u00e4ring HU, Hu FB, Schulze MB. Metabolically healthy obesity: epidemiology, mechanisms, and clinical implications. Lancet Diab Endocrinol. 2013;1(2):152\u201362.","journal-title":"Lancet Diab Endocrinol"},{"issue":"6","key":"2164_CR38","doi-asserted-by":"publisher","first-page":"R209","DOI":"10.1530\/EJE-14-0540","volume":"171","author":"M Bl\u00fcher","year":"2014","unstructured":"Bl\u00fcher M. Are metabolically healthy obese individuals really healthy? Eur J Endocrinol. 2014;171(6):R209\u201319.","journal-title":"Eur J Endocrinol"},{"issue":"12","key":"2164_CR39","doi-asserted-by":"publisher","first-page":"2778","DOI":"10.1111\/dom.13458","volume":"20","author":"KH Nam","year":"2018","unstructured":"Nam KH, Yun HR, Joo YS, Kim J, Lee S, Lee C, Park KS, Park JT, Chang TI, Kang EW, et al. Changes in obese metabolic phenotypes over time and risk of incident chronic kidney disease. Diabetes Obes Metab. 2018;20(12):2778\u201391.","journal-title":"Diabetes Obes Metab"},{"issue":"9","key":"2164_CR40","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1007\/s11255-014-0797-8","volume":"46","author":"C Wang","year":"2014","unstructured":"Wang C, Liang K, Zhang X, Li C, Yang W, Ma Z, Sun Y, Song J, Lin P, Gong L, et al. Metabolic abnormalities, but not obesity, contribute to the mildly reduced eGFR in middle-aged and elderly Chinese. Int Urol Nephrol. 2014;46(9):1793\u20139.","journal-title":"Int Urol Nephrol"},{"issue":"8","key":"2164_CR41","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1038\/ijo.2015.65","volume":"39","author":"HH Chen","year":"2015","unstructured":"Chen HH, Tseng YJ, Wang SY, Tsai YS, Chang CS, Kuo TC, Yao WJ, Shieh CC, Wu CH, Kuo PH. The metabolome profiling and pathway analysis in metabolic healthy and abnormal obesity. Int J Obes (2005). 2015;39(8):1241\u20138.","journal-title":"Int J Obes (2005)"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-020-02164-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12882-020-02164-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-020-02164-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T14:07:55Z","timestamp":1606226875000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-020-02164-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,24]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["2164"],"URL":"https:\/\/doi.org\/10.1186\/s12882-020-02164-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-37898\/v1","asserted-by":"object"}]},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,24]]},"assertion":[{"value":"22 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Ethics Committee of China Medical University (Shenyang, China AF-SDP-07-1, 0\u201301). All procedures were performed in accordance with ethical standards. Written consent was obtained from all participants after they had been informed of the objectives, benefits, medical items and confidentiality agreement regarding their personal information.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All the participants gave consent for direct quotes from their interviews to be used in this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"505"}}